Back Pain News and Research

Latest Back Pain News and Research

FDA approves tapentadol immediate-release tablets for pain in adults

Millions of Americans with moderate to severe acute pain and their health-care providers will soon have a new treatment option.

21 Nov 2008

Expectations drive patient preferences for treatment of spine problems

For patients with low back pain caused by a herniated disk, expectations of good results without surgery are the main factor affecting the preference for nonsurgical treatment, reports a study in the November 15 issue of Spine.

17 Nov 2008

First-ever international guidelines for the treatment of psoriatic arthritis

Rheumatologists, dermatologists, and patient advocates have come together to publish the first-ever international guidelines for the treatment of psoriatic arthritis, a disease that mainly affects people who have psoriasis but also some people without it.

26 Oct 2008

Hand, foot and mouth disease in China kills 3 children and sickens over 100 others

In the latest health scare in China three children have died from hand, foot and mouth disease and another 110 are sick - this is China's second outbreak of the virus this year in young children.

20 Oct 2008

Carbon nanotube coating improves electrical stimulation therapy used for Parkinson's, depression, chronic pain

Researchers at UT Southwestern Medical Center have designed a way to improve electrical stimulation of nerves by outfitting electrodes with the latest in chemically engineered fashion: a coating of basic black, formed from carbon nanotubes.

16 Sep 2008

FDA approves Gamunex for chronic inflammatory demyelinating polyneuropathy

The U.S. Food and Drug Administration has announced that it has approved an immune globulin product called Gamunex for the treatment of chronic inflammatory demyelinating polyneuropathy (CIDP), a rare autoimmune disorder characterized by progressive weakness and impaired sensory function in the legs and arms.

14 Sep 2008

Depression drug Cymbalta eases chronic back pain

A drug used to treat depression has been found to also be effective in reducing chronic low back pain.

28 Aug 2008

New imaging technology provides early diagnosis of osteoarthritis

A newly developed medical imaging technology may provide doctors with a long-awaited test for early diagnosis of osteoarthritis (OA), scientists from New York reported today at the 236th National Meeting of the American Chemical Society.

20 Aug 2008

Significant long-term benefit for low back pain revealed by major study

A major study led by a Southampton researcher has found significant evidence that the Alexander Technique can provide long-term benefit for people with chronic or recurrent low back pain.

20 Aug 2008

Alexander Technique shows long-term benefit for low back pain

A major study - one of the first of its kind - has found significant evidence that the Alexander Technique can provide long-term benefit for people suffering from chronic or recurrent low back pain. The study by researchers at the Universities of Bristol and Southampton is published today in the BMJ.

19 Aug 2008

Too many women ignorant of symptoms of ovarian cancer

A new survey had revealed that though ovarian cancer remains one of biggest gynaecological cancer killers, many women are unsure or unaware of the symptoms of the disease.

10 Aug 2008

New minimally invasive procedure successfully eliminates pain and disability caused by lumbar spinal stenosis

Early clinical results from the US and Argentina reveal that a new minimally invasive procedure successfully eliminates pain and disability caused by lumbar spinal stenosis (LSS), a condition that, in severe form, can cripple sufferers.

29 Jul 2008

Amgen announces positive results for Denosumab postmenopausal osteoporosis trial

Amgen has announced findings from the pivotal fracture trial evaluating its RANK Ligand inhibitor, denosumab, in the treatment of postmenopausal osteoporosis.

27 Jul 2008

Defining healthcare needs for chronic illness

A research paper in the latest issue of Medical Journal of Australia has provided the first insight into the prevalence and patterns of multimorbidity in Australia. About three in 10 people who saw a GP in 2005, and one in four Australians have multimorbidity (two or more types of chronic conditions).

22 Jul 2008

Back pain recovery slower than common belief suggests

A study by Australian researchers has found that recovery from low back pain is much slower than previously thought and is even slower for those with an injury which warrants compensation.

9 Jul 2008

ExpIND process speeds Alzheimer's drug research

Researchers are actively cutting the time and cost it normally takes to develop radiopharmaceuticals by taking advantage of "Exploratory Investigational New Drug" (ExpIND), an FDA-sanctioned procedure that enhances post-discovery drug development while observing scientific and patient safety standards.

16 Jun 2008

New treatments for lower back pain tested

"This is one of the most frustrating complaints that patients have as they get older." Physicians are testing two drugs approved to treat other conditions to see whether they might also help patients who have severe pain in their lower back and in their legs.

11 Jun 2008

Majority of kidney cancers diagnosed at earliest stage

Patients in the United States today are now much more likely to be diagnosed with smaller tumors, in the earliest, most treatable stage of kidney cancer than a decade ago, leading to a slightly higher survival rate, according to the results of a national study led by a UC San Diego Medical Center researcher.

19 May 2008

New guidelines say botulinum toxin effective for many neurological disorders, but not headache

New guidelines developed by the American Academy of Neurology confirm that the drug botulinum toxin is safe and effective for treating a variety of neurological conditions. Surprisingly, the drug may not be effective for chronic headaches, accrding to Allison Brashear, M.D., professor and chairman of the Department of Neurology at Wake Forest University Baptist Medical Center, who helped develop the guidelines.

9 May 2008

Botulinum toxin is safe and effective for treating cervical dystonia

New guidelines developed by the American Academy of Neurology confirm that the drug botulinum toxin is safe and effective for treating cervical dystonia, a condition of involuntary head tilt or neck movement, spasticity and other forms of muscle overactivity that interfere with movement in adults and children with an upper motor neuron syndrome, and excessive sweating of the armpits and hands.

5 May 2008